Show source-provided references
2. Gronwald, B., Kozłowska, L., Kijak, K., Lietz-Kijak, D., Skomro, P., Gronwald, K., and Gronwald, H. (2023). Nanoparticles in Dentistry—Current Literature Review. Coatings, 13.
10.3390/coatings13010102 ↗4. Alotaibi, N.H., Munir, M.U., Alruwaili, N.K., Alharbi, K.S., Ihsan, A., Almurshedi, A.S., Khan, I.U., Bukhari, S.N., Rehman, M., and Ahmad, N. (2022). Synthesis and characterization of antibiotic–loaded biodegradable citrate functionalized mesoporous hydroxyapatite nanocarriers as an alternative treatment for bone infections. Pharmaceutics, 14.
10.3390/pharmaceutics14050975 ↗5. Alhasan, H.S., Yasin, S.A., Alahmadi, N., and Alkhawaldeh, A.K. (2023). The Application of Hydroxyapatite NPs for Adsorption Antibiotic from Aqueous Solutions: Kinetic, Thermodynamic, and Isotherm Studies. Processes, 11.
10.3390/pr11030749 ↗6. Enhanced Hemolytic Biocompatibility of Hydroxyapatite by Chromium (Cr³+) Doping in Hydroxyapatite Nanoparticles Synthesized by Solution Combustion Method
10.4191/kcers.2017.54.2.11 ↗8. Zinc and Chromium Co-Doped Calcium Hydroxyapatite: Sol-Gel Synthesis, Characterization, Behaviour in Simulated Body Fluid and Phase Transformations
10.1016/j.jssc.2020.121202 ↗10. Synthesis of Functionally Graded Bioactive Glass-Apatite Multistructures on Ti Substrates by Pulsed Laser Deposition
10.1016/j.apsusc.2007.08.009 ↗11. Multiscale connections between morphology and chemistry in crystalline, zinc-substituted hydroxyapatite nanofilms designed for biomedical applications
10.1016/j.ceramint.2018.09.246 ↗19. Trivalent Chromium Incorporated in a Crystalline Calcium Phosphate Matrix Accelerates Materials Degradation and Bone Formation in Vivo
10.1016/j.actbio.2018.01.010 ↗20. Collery, P., Maymard, Y., Theophanides, T., Khassanova, L., and Collery, T. (2008). Metal Ions in Biology, J. John Libbey.
22. Production and Characterization of Pure and Cr3+-Doped Hydroxyapatite for Biomedical Applications as Fluorescent Probes
10.1007/s10853-006-0536-3 ↗23. Enhanced Visible Light Photocatalytic Activity of Cr3+-Doped Anatase TiO2 Nanoparticles Synthesized by Sol–Gel Method
10.1007/s10854-015-3785-6 ↗25. Balamurugan, K., Vasant, C., Rajaram, R., and Ramasami, T. (1999). Hydroxopentaamminechromium(III) promoted phosphorylation of bovine serum albumin: Its potential implications in understanding biotoxicity of chromium. Biochim Biophys Acta, 1427.
10.1016/S0304-4165(99)00047-1 ↗26. ATSDR (2024, October 30). Agency for Toxic Substances and Disease Registry (2000) Toxicological Profile for Chromium. Syracuse. US Department of Health & Human Services, Available online: https://wwwn.cdc.gov/TSP/ToxProfiles/ToxProfiles.aspx?id=62&tid=17.
27. Cimpeanu, C., Predoi, D., Ciobanu, C.S., Iconaru, S.L., Rokosz, K., Predoi, M.V., Raaen, S., and Badea, M.L. (2024). Development of Novel Biocomposites with Antimicrobial-Activity-Based Magnesium-Doped Hydroxyapatite with Amoxicillin. Antibiotics, 13.
10.3390/antibiotics13100963 ↗29. Predoi, D., Iconaru, S.L., Predoi, M.V., Motelica-Heino, M., Buton, N., and Megier, C. (2020). Obtaining and Characterizing Thin Layers of Magnesium Doped Hydroxyapatite by Dip Coating Procedure. Coatings, 10.
10.3390/coatings10060510 ↗30. Predoi, D., Iconaru, S.L., Predoi, M.V., Motelica-Heino, M., Guegan, R., and Buton, N. (2019). Evaluation of Antibacterial Activity of Zinc-Doped Hydroxyapatite Colloids and Dispersion Stability Using Ultrasounds. Nanomaterials, 9.
10.3390/nano9040515 ↗31. Interference of irregularly oriented particles in X-rays
32. Interference on inordinate orientated particles in X-ray light. III
34. Barrett, C.S., Cohen, J.B., Faber, J., Jenkins, R., Leyden, D.E., Russ, J.C., and Predecki, P.K. (1986). Advances in X-ray Analysis, Plenum Publishing. [2nd ed.].
36. Casa Software Ltd (2022, September 30). CasaXPS: Processing Software for XPS, AES, SIMS and More. Available online: www.casaxps.com.
37. Resolving surface chemical states in XPS analysis of first row transition metals, oxides and hydroxides: Sc, Ti, V, Cu and Zn
10.1016/j.apsusc.2010.07.086 ↗38. Wagner, C.D., Naumkin, A.V., Kraut-Vass, A., Allison, J.W., Powell, C.J., and Rumble, J.R. (2024, November 20). NIST Standard Reference Database 20, Version 3.4, Available online: https://srdata.nist.gov/xps.
39. (2024, October 01). Gwyddion. Available online: http://gwyddion.net/.
40. Study on Europium-Doped Hydroxyapatite Nanoparticles by Fourier Transform Infrared Spectroscopy and Their Antimicrobial Properties
10.1155/2013/284285 ↗41. Iconaru, S.L., Predoi, D., Ciobanu, C.S., Motelica-Heino, M., Guegan, R., and Bleotu, C. (2022). Development of Silver Doped Hydroxyapatite Coatings for Biomedical Applications. Coatings, 12.
10.3390/coatings12030341 ↗42. (2024, November 20). ImageJ, Available online: http://imagej.nih.gov/ij.
43. Ciobanu, C.S., Iconaru, S.L., Predoi, D., Trușcă, R.-D., Prodan, A.M., Groza, A., Chifiriuc, M.C., and Beuran, M. (2021). Fabrication of Novel Chitosan–Hydroxyapatite Nanostructured Coatings for Biomedical Applications. Coatings, 11.
10.3390/coatings11121561 ↗44. Kittel, C. (1996). Introduction to Solid State Physics. Introduction to Solid State Physics, Wiley. [7th ed.].
45. Synthesis and Crystal Phase Evaluation of Hydroxylapatite Using the Rietveld-Maximum Entropy Method
47. Manoj, M., Subbiah, R., Mangalaraj, D., Ponpandian, N., Viswanathan, C., and Park, K. (2015). Influence of Growth Parameters on the Formation of Hydroxyapatite (HAp) Nanostructures and Their Cell Viability Studies. Nanobiomedicine, 2.
10.5772/60116 ↗49. (2018). Biological Evaluation of Medical Devices–Part 1: Evaluation and Testing within a Risk Management Process (Standard No. ISO 10993-1:2018). Available online: https://www.iso.org/standard/68936.html.
50. In vitro cytocompatibility and antibacterial studies on biodegradable Zn alloys supplemented by a critical assessment of direct contact cytotoxicity assay
10.1002/jbm.b.35147 ↗51. Sukumaran, A., and Mahmoud, A.M. (2023). Cytotoxicity and Cell Viability Assessment of Biomaterials. Cytotoxicity-Understanding Cellular Damage and Response, Intech Open.
10.5772/intechopen.111822 ↗52. Effectiveness and Safety of Antibiotic Prophylaxis for Persons Exposed to Cases of Invasive Group a Streptococcal Disease: A Systematic Review
10.1093/ofid/ofac244 ↗53. Amoxicillin: A Broad-Spectrum Antibiotic
54. A Review on Hydroxyapatite Coatings for Biomedical Applications: Experimental and Theoretical Perspectives
10.1039/D0TB02407D ↗55. Multisubstituted Hydroxyapatite Powders and Coatings: The Influence of the Codoping on the Hydroxyapatite Performances
10.1111/ijac.13229 ↗57. Predoi, D., Iconaru, S.L., and Predoi, M.V. (2019). Dextran-Coated Zinc-Doped Hydroxyapatite for Biomedical Applications. Polymers, 11.
10.3390/polym11050886 ↗58. Predoi, D., Iconaru, S.L., Ciobanu, S.C., Predoi, S.-A., Buton, N., Megier, C., and Beuran, M. (2021). Development of Iron-Doped Hydroxyapatite Coatings. Coatings, 11.
10.3390/coatings11020186 ↗59. Predoi, S.A., Ciobanu, S.C., Chifiriuc, M.C., Motelica-Heino, M., Predoi, D., and Iconaru, S.L. (2023). Hydroxyapatite Nanopowders for Effective Removal of Strontium Ions from Aqueous Solutions. Materials, 16.
10.3390/ma16010229 ↗62. Resistance to β-lactam antibiotics in Pseudomonas aeruginosa
63. Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
10.1086/338782 ↗66. Amoxicillin Encapsulation on Alginate/Magnetite Composite and Its Antimicrobial Properties Against Gram-Negative and Positive Microbes
10.1007/s12668-022-01038-1 ↗67. Amoxicillin and Potassium Clavulanate: An Antibiotic Combination Mechanism of Action, Pharmacokinetics, Antimicrobial Spectrum, Clinical Efficacy and Adverse Effects
10.1002/j.1875-9114.1984.tb03333.x ↗68. Development and characterization of polymeric-based nanoparticles for sustained release of amoxicillin—An antimicrobial drug
10.1080/21691401.2018.1476371 ↗69. Improvement of mechanical and antibacterial features of hydroxyapatite/chromium oxide/graphene oxide nanocomposite for biomedical utilizations
10.1016/j.surfcoat.2022.128476 ↗70. Antibacterial efficacy and cytotoxicity studies of copper (II) and titanium (IV) substituted hydroxyapatite nanoparticles
10.1016/j.msec.2010.06.011 ↗71. Effects of metal compounds with distinct physicochemical properties on iron homeostasis and antibacterial activity in the lungs: Chromium and vanadium
10.3109/08958370903161232 ↗